We are live on ! Find out more
Walsh & Associates

Walsh & Associates Portfolio holdings

AUM $130M Turnover 9.06%
1-Year Est. Return 15.31%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+15.31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$7.69M
Cap. Flow
+$7.23M
Cap. Flow %
5.56%
Top 10 Hldgs %
65.39%
Holding
265
New
20
Increased
62
Reduced
40
Closed
4
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.7 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PFE icon
226
Pfizer
PFE
$156B
$4.28K ﹤0.01%
+150
New +$3.99K
2026 Q3
0 quarters
EPI icon
227
WisdomTree India Earnings Fund ETF
EPI
$1.92B
$4.07K ﹤0.01%
100
– –
2025 Q4
3 quarters
GSK icon
228
GSK
GSK
$95.7B
$3.85K ﹤0.01%
80
– –
2025 Q4
3 quarters
PNC icon
229
PNC Financial Services
PNC
$84.7B
$3.78K ﹤0.01%
+17
New +$4.17K
2026 Q3
0 quarters
MRK icon
230
Merck
MRK
$330B
$3.63K ﹤0.01%
+25
New +$3.46K
2026 Q3
0 quarters
PEG icon
231
Public Service Enterprise Group
PEG
$36.8B
$3.23K ﹤0.01%
48
– –
2025 Q4
3 quarters
OTIS icon
232
Otis Worldwide
OTIS
$29B
$3.22K ﹤0.01%
50
– –
2025 Q4
3 quarters
BMY icon
233
Bristol-Myers Squibb
BMY
$120B
$3.12K ﹤0.01%
+50
New +$3.16K
2026 Q3
0 quarters
SCHB icon
234
Schwab US Broad Market ETF
SCHB
$40.6B
$2.46K ﹤0.01%
84
– –
2025 Q4
3 quarters
WM icon
235
Waste Management
WM
$95.3B
$2.45K ﹤0.01%
+12
New +$2.69K
2026 Q3
0 quarters
GEHC icon
236
GE HealthCare
GEHC
$36.5B
$1.83K ﹤0.01%
28
+27
+2,700% +$1.83K
2025 Q4
3 quarters
MELI icon
237
Mercado Libre
MELI
$68.7B
$1.73K ﹤0.01%
+1
New +$1.86K
2026 Q3
0 quarters
UBER icon
238
Uber
UBER
$130B
$1.71K ﹤0.01%
25
-184
-88% -$13.5K
2025 Q4
3 quarters
KNSL icon
239
Kinsale Capital Group
KNSL
$8.97B
$1.61K ﹤0.01%
5
– –
2025 Q4
3 quarters
NEE icon
240
NextEra Energy
NEE
$175B
$1.51K ﹤0.01%
20
– –
2025 Q4
3 quarters
NOC icon
241
Northrop Grumman
NOC
$75.9B
$1.45K ﹤0.01%
3
– –
2025 Q4
3 quarters
GME icon
242
GameStop
GME
$13.4B
$961 ﹤0.01%
39
– –
2025 Q4
3 quarters
ICSH icon
243
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.91B
$907 ﹤0.01%
18
– –
2026 Q2
1 quarter
HLN icon
244
Haleon
HLN
$39.8B
$900 ﹤0.01%
100
– –
2025 Q4
3 quarters
HUBS icon
245
HubSpot
HUBS
$9.47B
$820 ﹤0.01%
4
– –
2025 Q4
3 quarters
IXUS icon
246
iShares Core MSCI Total International Stock ETF
IXUS
$52.6B
$784 ﹤0.01%
8
– –
2025 Q4
3 quarters
VIK icon
247
Viking Holdings
VIK
$41.6B
$783 ﹤0.01%
10
– –
2025 Q4
3 quarters
VBK icon
248
Vanguard Morningstar Small-Cap Growth ETF
VBK
$20.3B
$676 ﹤0.01%
2
– –
2025 Q4
3 quarters
PJT icon
249
PJT Partners
PJT
$3.55B
$570 ﹤0.01%
4
– –
2025 Q4
3 quarters
ORCL icon
250
Oracle
ORCL
$315B
$412 ﹤0.01%
+3
New +$423
2026 Q3
0 quarters

Similar funds

Walsh & Associates's Q3 2026 Portfolio in Review

As of Q3 2026, Walsh & Associates held 265 positions worth $130M, up 6.3% from $122M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Walsh & Associates deployed $7.23M of net new capital in Q3 2026, opening 20 new positions and adding to 62 existing holdings. Its largest new stake was Citigroup: 145 shares worth $18.8K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 86% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was NVIDIA, an estimated $380K trimmed.

  • Walsh & Associates's largest Q3 2026 buy was Citigroup: 145 shares worth $18.8K.
  • Walsh & Associates added most to State Street SPDR Portfolio Developed World ex-US ETF in Q3 2026, an estimated $1.83M increase.
  • Walsh & Associates's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $380K.
  • Walsh & Associates fully exited State Street SPDR Russell 1000 Yield Focus ETF in Q3 2026, selling an estimated $53.2K.
  • Walsh & Associates's ten largest holdings make up 65% of its $130M portfolio in Q3 2026.
  • Walsh & Associates opened 20 new positions and closed 4 in Q3 2026.
  • Walsh & Associates's portfolio value rose 6.3% quarter-over-quarter to $130M.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.